| Literature DB >> 29467218 |
Spencer G Willet1, Mark A Lewis1, Zhi-Feng Miao1,2, Dengqun Liu3, Megan D Radyk1, Rebecca L Cunningham4, Joseph Burclaff1, Greg Sibbel1, Hei-Yong G Lo1, Valerie Blanc1, Nicholas O Davidson1, Zhen-Ning Wang5, Jason C Mills6,4,7.
Abstract
In 1900, Adami speculated that a sequence of context-independent energetic and structural changes governed the reversion of differentiated cells to a proliferative, regenerative state. Accordingly, we show here that differentiated cells in diverse organs become proliferative via a shared program. Metaplasia-inducing injury caused both gastric chief and pancreatic acinar cells to decrease mTORC1 activity and massively upregulate lysosomes/autophagosomes; then increase damage associated metaplastic genes such as Sox9; and finally reactivate mTORC1 and re-enter the cell cycle. Blocking mTORC1 permitted autophagy and metaplastic gene induction but blocked cell cycle re-entry at S-phase. In kidney and liver regeneration and in human gastric metaplasia, mTORC1 also correlated with proliferation. In lysosome-defective Gnptab-/- mice, both metaplasia-associated gene expression changes and mTORC1-mediated proliferation were deficient in pancreas and stomach. Our findings indicate differentiated cells become proliferative using a sequential program with intervening checkpoints: (i) differentiated cell structure degradation; (ii) metaplasia- or progenitor-associated gene induction; (iii) cell cycle re-entry. We propose this program, which we term "paligenosis", is a fundamental process, like apoptosis, available to differentiated cells to fuel regeneration following injury.Entities:
Keywords: dedifferentiation; regeneration; repair; reprogramming; transdifferentiation
Mesh:
Substances:
Year: 2018 PMID: 29467218 PMCID: PMC5881627 DOI: 10.15252/embj.201798311
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598